The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

297 Ertaş, R., Ozyurt, K., Atasoy, M., Hawro, T., and Maurer, M.+: The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change. Allergy 2018: 73; 705-712. IF: 6.77